Olmesartan reduces arterial stiffness and serum adipocyte fatty acid-binding protein in hypertensive patients (Q82387808)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21063874%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

title

Olmesartan reduces arterial stiffness and serum adipocyte fatty acid-binding protein in hypertensive patients (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21063874%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

1 reference

Toru Miyoshi

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21063874%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Masayuki Doi

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21063874%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Satoshi Hirohata

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21063874%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Shigeshi Kamikawa

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21063874%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Shinichi Usui

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21063874%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Hiroko Ogawa

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21063874%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Kosuke Sakane

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21063874%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Reishi Izumi

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21063874%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Yoshifumi Ninomiya

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21063874%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Shozo Kusachi

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21063874%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

publication date

10 November 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21063874%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21063874%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

volume

26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21063874%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21063874%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

page(s)

408-413

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21063874%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00380-010-0060-x

16 January 2020

exact match

0 references

cites work

Olmesartan ameliorates myocardial function independent of blood pressure control in patients with mild-to-moderate hypertension.

1 reference

12 December 2020

Use of 24-hour ambulatory blood pressure monitoring to assess antihypertensive efficacy: a comparison of olmesartan medoxomil, losartan potassium, valsartan, and irbesartan

1 reference

12 December 2020

Association of new arterial stiffness parameter, the cardio-ankle vascular index, with left ventricular diastolic function

1 reference

12 December 2020

The association of serum adipocyte fatty acid-binding protein with coronary artery disease in Korean adults

1 reference

12 December 2020

Comparative efficacy of olmesartan, losartan, valsartan, and irbesartan in the control of essential hypertension

1 reference

12 December 2020

Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial

1 reference

12 December 2020

Antiinflammatory effects of angiotensin II subtype 1 receptor blockade in hypertensive patients with microinflammation

1 reference

12 December 2020

Molecular activation of PPARgamma by angiotensin II type 1-receptor antagonists

1 reference

12 December 2020

A novel blood pressure-independent arterial wall stiffness parameter; cardio-ankle vascular index (CAVI).

1 reference

12 December 2020

Assessment of arterial distensibility by automatic pulse wave velocity measurement. Validation and clinical application studies.

1 reference

12 December 2020

World Medical Association Declaration of Helsinki. Recommendations guiding physicians in biomedical research involving human subjects

1 reference

12 December 2020

Uncoupling of obesity from insulin resistance through a targeted mutation in aP2, the adipocyte fatty acid binding protein

1 reference

12 December 2020

Favorable cardiac and aortic remodeling in olmesartan-treated spontaneously hypertensive rats.

1 reference

12 December 2020

Serum adipocyte fatty acid-binding protein levels were independently associated with carotid atherosclerosis

1 reference

12 December 2020

Risk of new-onset diabetes in the Losartan Intervention For Endpoint reduction in hypertension study

1 reference

12 December 2020

Adipocyte fatty acid-binding protein expression and lipid accumulation are increased during activation of murine macrophages by toll-like receptor agonists.

1 reference

12 December 2020

Cytoplasmic fatty acid-binding proteins: emerging roles in metabolism and atherosclerosis

1 reference

12 December 2020

Olmesartan ameliorates progressive glomerular injury in subtotal nephrectomized rats through suppression of superoxide production

1 reference

12 December 2020

The fatty acid-binding protein, aP2, coordinates macrophage cholesterol trafficking and inflammatory activity. Macrophage expression of aP2 impacts peroxisome proliferator-activated receptor gamma and IkappaB kinase activities

1 reference

12 December 2020

The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2009)

1 reference

12 December 2020

Adipocyte fatty acid-binding protein is a plasma biomarker closely associated with obesity and metabolic syndrome.

1 reference

12 December 2020

Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-kappaB signaling through a cAMP-dependent pathway

1 reference

12 December 2020

Fatty acid binding protein 4 is increased in metabolic syndrome and with thiazolidinedione treatment in diabetic patients.

1 reference

12 December 2020

Effects of candesartan on the development of a new diagnosis of diabetes mellitus in patients with heart failure

1 reference

12 December 2020

Availability of cardio-ankle vascular index (CAVI) as a screening tool for atherosclerosis

1 reference

12 December 2020

Adiponectin: more than just another fat cell hormone?

1 reference

12 December 2020

Serum adipocyte fatty acid-binding protein is independently associated with coronary atherosclerotic burden measured by intravascular ultrasound

1 reference

12 December 2020

Prevalence of insulin resistance in essential hypertension.

1 reference

12 December 2020

The metabolic syndrome as a concept of adipose tissue disease

1 reference

12 December 2020

Angiotensin II receptor blocker reduces oxidative stress and attenuates hypoxia-induced left ventricular remodeling in apolipoprotein E-knockout mice

1 reference

12 December 2020

Lack of macrophage fatty-acid-binding protein aP2 protects mice deficient in apolipoprotein E against atherosclerosis

1 reference

12 December 2020

Serum adipocyte fatty acid binding protein as a new biomarker predicting the development of type 2 diabetes: a 10-year prospective study in a Chinese cohort.

1 reference

12 December 2020

Relationship between activin A level and infarct size in patients with acute myocardial infarction undergoing successful primary coronary intervention

1 reference

12 December 2020

Serum interferon-gamma-inducible protein 10 level was increased in myocardial infarction patients, and negatively correlated with infarct size

1 reference

12 December 2020